Nova Eye Medical Ltd
ASX:EYE
Nova Eye Medical Ltd
Cash from Operating Activities
Nova Eye Medical Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Nova Eye Medical Ltd
ASX:EYE
|
Cash from Operating Activities
-AU$6.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Cash from Operating Activities
-AU$12.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-8%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash from Operating Activities
-AU$7.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
Cochlear Ltd
ASX:COH
|
Cash from Operating Activities
AU$430.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
5%
|
CAGR 10-Years
19%
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cash from Operating Activities
-AU$5.6m
|
CAGR 3-Years
-115%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-23%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash from Operating Activities
AU$834.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Nova Eye Medical Ltd's Cash from Operating Activities?
Cash from Operating Activities
-6.8m
AUD
Based on the financial report for Jun 30, 2023, Nova Eye Medical Ltd's Cash from Operating Activities amounts to -6.8m AUD.
What is Nova Eye Medical Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
-45%
Over the last year, the Cash from Operating Activities growth was -45%.